Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.415
-0.005 (-0.35%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Vivani Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.89 | 16.23 | 18.35 | 20.65 | 45.08 | 2.18 |
Cash & Short-Term Investments | 19.89 | 16.23 | 18.35 | 20.65 | 45.08 | 2.18 |
Cash Growth | 192.82% | -11.55% | -11.15% | -54.18% | 1969.61% | 4.66% |
Other Receivables | 0.71 | 0.65 | 0.25 | - | - | - |
Receivables | 0.71 | 0.65 | 0.25 | - | - | - |
Prepaid Expenses | 1.03 | 1.01 | 1.84 | 2.41 | 2.45 | 0.29 |
Total Current Assets | 21.64 | 17.9 | 20.44 | 23.06 | 47.53 | 2.47 |
Property, Plant & Equipment | 19.02 | 20.11 | 19.65 | 21.35 | 1.96 | 2.78 |
Other Long-Term Assets | 0.99 | 1.39 | 1.47 | 1.39 | 1.64 | 0.2 |
Total Assets | 41.64 | 39.39 | 41.56 | 45.8 | 51.13 | 5.45 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.2 | 1.03 | 0.82 | 0.54 | 1.18 | 0.28 |
Accrued Expenses | 1.61 | 1.77 | 1.81 | 1.79 | 4.31 | 0.9 |
Current Portion of Leases | 1.84 | 1.79 | 1.35 | 1.38 | 0.96 | 0.91 |
Current Unearned Revenue | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | - |
Other Current Liabilities | 1.68 | 1.68 | 1.68 | 1.68 | 0.05 | - |
Total Current Liabilities | 6.66 | 6.6 | 5.99 | 5.72 | 6.82 | 2.09 |
Long-Term Leases | 16.01 | 17.06 | 17.97 | 19.31 | - | 0.9 |
Total Liabilities | 22.67 | 23.66 | 23.95 | 25.04 | 6.82 | 2.99 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 54.65 |
Additional Paid-In Capital | 180.61 | 164.23 | 139.48 | 119.05 | 117.05 | 6.71 |
Retained Earnings | -161.68 | -148.53 | -121.92 | -98.44 | -72.79 | -58.9 |
Comprehensive Income & Other | 0.03 | 0.03 | 0.05 | 0.14 | 0.04 | - |
Shareholders' Equity | 18.97 | 15.73 | 17.61 | 20.76 | 44.31 | 2.47 |
Total Liabilities & Equity | 41.64 | 39.39 | 41.56 | 45.8 | 51.13 | 5.45 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.86 | 18.86 | 19.31 | 20.7 | 0.96 | 1.81 |
Net Cash (Debt) | 2.04 | -2.62 | -0.96 | -0.04 | 44.12 | 0.37 |
Net Cash Growth | - | - | - | - | 11954.92% | - |
Net Cash Per Share | 0.03 | -0.04 | -0.02 | -0.00 | 1.15 | 0.01 |
Filing Date Shares Outstanding | 90.2 | 84.65 | 59.24 | 54.98 | 50.74 | 12.19 |
Total Common Shares Outstanding | 89.41 | 76.43 | 59.23 | 51.03 | 50.74 | 12.19 |
Working Capital | 14.98 | 11.3 | 14.46 | 17.34 | 40.71 | 0.38 |
Book Value Per Share | 0.21 | 0.21 | 0.30 | 0.41 | 0.87 | 0.20 |
Tangible Book Value | 18.97 | 15.73 | 17.61 | 20.76 | 44.31 | 2.47 |
Tangible Book Value Per Share | 0.21 | 0.21 | 0.30 | 0.41 | 0.87 | 0.20 |
Machinery | 2.99 | 4.54 | 4.3 | 3.87 | 3.53 | 3.18 |
Construction In Progress | 1.15 | 1.36 | - | 0.3 | - | - |
Leasehold Improvements | - | - | - | - | 0.01 | 0.01 |